Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 56,400 shares traded.
Resverlogix Trading Up 5.0%
The firm’s 50-day moving average is C$0.10 and its 200-day moving average is C$0.10. The company has a current ratio of 0.03, a quick ratio of 0.04 and a debt-to-equity ratio of -83.11. The firm has a market cap of C$33.28 million, a price-to-earnings ratio of -5.25 and a beta of 0.41.
Resverlogix (TSE:RVX – Get Free Report) last released its quarterly earnings data on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share for the quarter. As a group, sell-side analysts anticipate that Resverlogix Corp. will post -0.22 EPS for the current fiscal year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
